Kolovrat et al., 2020) appears as the specific effect of BPC 157 in ischemia/reperfusion (Vukojevic et al., 2018
He L, Feng D, Guo H, Zhou Y, Li Z, Zhang K, et al
BPC 157, a pentadecapeptide, is renowned for its ability to accelerate the healing of soft tissue injuries, including muscles, tendons, ligaments, and nerves
requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%
This maintains optimal blood flow to injured areas
Its unique ability to inhibit melanin synthesis makes it indispensable for achieving a luminous, even skin tone and reducing pesky dark spots